ArticleHepatology communications2025

PolyIC as an adjuvant outperforms anti-VEGF in combination with anti-PD-L1 therapy in mouse liver tumor models.

Yichun Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.